Karolinska University Hospital-ko ikertzaileekin lankidetzan egindako argitalpenak (45)

2023

  1. Thrombectomy versus Medical Management for Isolated Anterior Cerebral Artery Stroke: An International Multicenter Registry Study

    Radiology, Vol. 307, Núm. 2

2022

  1. Plasma proteins elevated in severe asthma despite oral steroid use and unrelated to Type-2 inflammation

    European Respiratory Journal, Vol. 59, Núm. 2

  2. Thrombectomy for secondary distal, medium vessel occlusions of the posterior circulation: seeking complete reperfusion

    Journal of NeuroInterventional Surgery, Vol. 14, Núm. 7, pp. 654-659

2021

  1. Clonogenic Assays to Detect Cell Fate in Mitotic Catastrophe

    Methods in Molecular Biology (Humana Press Inc.), pp. 227-239

  2. Effects of acyl-coenzyme A binding protein (ACBP)/diazepam-binding inhibitor (DBI) on body mass index

    Cell Death and Disease, Vol. 12, Núm. 6

  3. Everolimus and plicamycin specifically target chemoresistant colorectal cancer cells of the CMS4 subtype

    Cell Death and Disease, Vol. 12, Núm. 11

  4. Urinary Leukotriene E4 and Prostaglandin D2 Metabolites Increase in Adult and Childhood Severe Asthma Characterized by Type 2 Inflammation

    American Journal of Respiratory and Critical Care Medicine, Vol. 203, Núm. 1, pp. 37-53

2020

  1. Antibody-mediated neutralization of ACBP/DBI has anorexigenic and lipolytic effects

    Adipocyte, Vol. 9, Núm. 1, pp. 116-119

  2. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

    Nature Genetics, Vol. 52, Núm. 1, pp. 56-73

  3. Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer

    Nature Communications, Vol. 11, Núm. 1

  4. Publisher Correction: Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer (Nature Communications, (2020), 11, 1, (3819), 10.1038/s41467-020-17644-0)

    Nature Communications

2019

  1. Author Correction: Crizotinib-induced immunogenic cell death in non-small cell lung cancer (Nature Communications, (2019), 10, 1, (1486), 10.1038/s41467-019-09415-3)

    Nature Communications

  2. Crizotinib-induced immunogenic cell death in non-small cell lung cancer

    Nature Communications, Vol. 10, Núm. 1

  3. Epithelial dysregulation in obese severe asthmatics with gastro-oesophageal reflux

    European Respiratory Journal

  4. Suppression of tumor antigen presentation during aneuploid tumor evolution contributes to immune evasion

    OncoImmunology, Vol. 8, Núm. 11

2018

  1. A computational framework for complex disease stratification from multiple large-scale datasets

    BMC Systems Biology, Vol. 12, Núm. 1

  2. Calcium signaling and cell cycle: Progression or death

    Cell Calcium, Vol. 70, pp. 3-15

  3. Immune effectors responsible for the elimination of hyperploid cancer cells

    OncoImmunology, Vol. 7, Núm. 8

  4. eIF2α phosphorylation is pathognomonic for immunogenic cell death

    Cell Death and Differentiation, Vol. 25, Núm. 8, pp. 1375-1393

2017

  1. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

    Nature Genetics, Vol. 49, Núm. 5, pp. 680-691